Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination dietary supplement containing **white kidney bean extract** (WKBE) and a **polyphenol mix extract**. **White kidney bean extract** is obtained from Phaseolus vulgaris and is primarily known for its ability to inhibit alpha-amylase, an enzyme responsible for digesting starches, potentially slowing carbohydrate absorption and supporting weight management. **Polyphenol mix extract** generally includes a mixture of plant-derived polyphenols, which are compounds with significant antioxidant and anti-inflammatory properties. When combined, these components are regarded as nutraceuticals aimed at supporting metabolic health, reducing body weight and fat accumulation, improving blood lipid profiles, enhancing glucose metabolism, and positively influencing gut microbiota. The mechanism of action includes alpha-amylase inhibition (for WKBE), antioxidant activity, anti-inflammatory effects, modulation of gut microbiota, and support for metabolic and cardiovascular health. This combination is typically developed and marketed as a dietary/nutraceutical supplement for general metabolic health and weight management, not as a pharmaceutical drug[1][13][8][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on white kidney bean extract + polyphenol mix extract.